Clinical Trial Update: Study In Patients With Dyslipidaemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in patients with dyslipidaemia/metabolic syndrome has been completed; sponsor GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Metabolic Syndrome

Snippet

Sponsor: GlaxoSmithKline | Conditions: Metabolic Syndrome X | Phase 2 | Status: COMPLETED